Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication.

Yuchen ChenDong YangBiao ChengJian ChenAnlin PengChen YangChong LiuMingrui XiongAiping DengYu ZhangLing Zheng Kun Huang

Published in: Diabetes care (2020)

C-reactive protein may help to identify patients with diabetes who are at greater risk of dying during hospitalization. Older patients with diabetes were prone to death related to COVID-19. Attention needs to be paid to patients with diabetes and COVID-19 who use insulin. ACEI/ARB use showed no significant impact on patients with diabetes and hypertension who have COVID-19.

Keyphrases

coronavirus disease
sars cov
type diabetes
blood pressure
palliative care
respiratory syndrome coronavirus
physical activity
working memory
emergency department
metabolic syndrome
glycemic control
skeletal muscle
blood glucose